Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine

作者: John Vincent , Stuart I. Harris , George Foulds , Lisa C. Dogolo , Susan Willavize

DOI: 10.1046/J.1365-2125.2000.00283.X

关键词:

摘要: Aims To determine whether repeated once daily administration of grapefruit juice altered the pharmacokinetics or pharmacodynamics calcium antagonist amlodipine. Methods The effects on and oral intravenous amlodipine were assessed in 20 healthy men a placebo-controlled, open, randomized, four-way crossover study using single doses 10 mg. For 9 days beginning with day amlodipine, (or water control) was given daily, blood samples, pressure heart rate measures obtained. Plasma concentrations its enantiomers determined separate assays by GC-ECD. Results Oral had high systemic availability (grapefruit juice: 88%; water: 81%). Pharmacokinetic parameters racemic (AUC, Cmax, tmax, kel) not markedly changed coadministration. Total plasma clearance volume distribution, calculated after essentially unchanged (CL 6.65 ml min x1 kg , vs 6.93 water; Vdss 22.7 l 21.0 water). Grapefruit coadministration did greatly alter stereoselectivity kinetics. sum S(‐) R(+) enantiomer correlated well total concentration (r 2 =0.957; P=0.0001). Coadministration either route significantly changes control. Conclusions has no appreciable effect pharmacokinetics, including stereoselective Bioavailability enhancement juice, noted other dihydropyridine antagonists, does occur Once usual is unlikely to profile response clinical practice.

参考文章(27)
D. G. Bailey, J. R. Bend, J. M. O. Arnold, J. D. Spence, L. T. Tran, Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation. British Journal of Clinical Pharmacology. ,vol. 40, pp. 135- 140 ,(1995)
Stephan Döppenschmitt, Hildegard Spahn‐Langguth, Carl Gunnar Regårdh, Peter Langguth, Radioligand-Binding Assay Employing P-Glycoprotein-Overexpressing Cells: Testing Drug Affinities to the Secretory Intestinal Multidrug Transporter Pharmaceutical Research. ,vol. 15, pp. 1001- 1006 ,(1998) , 10.1023/A:1011965707998
F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, M. C. Willingham, Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 7735- 7738 ,(1987) , 10.1073/PNAS.84.21.7735
H TAKANAGA, A OHNISHI, H MURAKAMI, H MATSUO, S HIGUCHI, A URAE, S IRIE, H FURUIE, K MATSUKUMA, M KIMURA, Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects. Clinical Pharmacology & Therapeutics. ,vol. 67, pp. 201- 214 ,(2000) , 10.1067/MCP.2000.104215
F. Peter Guengerich, William R. Brian, Masahiko Iwasaki, Marie Agnes Sari, Catharina Baeaernhielm, Peder Berntsson, Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4. Journal of Medicinal Chemistry. ,vol. 34, pp. 1838- 1844 ,(1991) , 10.1021/JM00110A012
Barbara Ameer, Randy A. Weintraub, Drug interactions with grapefruit juice Clinical Pharmacokinectics. ,vol. 33, pp. 103- 121 ,(1997) , 10.2165/00003088-199733020-00003
Knud Erik Pedersen, Anton Dorph-Pedersen, Steffen Hvidt, Niels Anders Klitgaard, Folmer Nielsen-Kudsk, Digoxin-verapamil interaction Clinical Pharmacology and Therapeutics. ,vol. 30, pp. 311- 316 ,(1981) , 10.1038/CLPT.1981.165
K KIVISTO, J LILJA, J BACKMAN, P NEUVONEN, Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride Clinical Pharmacology & Therapeutics. ,vol. 66, pp. 448- 453 ,(1999) , 10.1016/S0009-9236(99)70007-X